Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ping An To Invest RMB 500 Million In Healthcare Industry

This article was originally published in PharmAsia News

Executive Summary

Ping An Trust & Investment, a subsidiary of Ping An Insurance (Group), and Guangzhou Zhongda Holding have jointly set up the Guangzhou Yikang clinic chain with a total investment of RMB 200-500 million ($29.3-73 million). This represents Ping An's first launch of medical institutions since it entered the healthcare industry. With funding of RMB 8 million, the first Yikang clinic took about one year to go into operation, including negotiations, approval, location set-up and recruitment. Ten more clinics will be opened in the Pearl River Delta this year. Yikang will engage Hong Kong-based Town Health International Holdings as its management consultant to introduce an advanced medical service model. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel